SCG Cell Therapy Pte. Ltd.
🇸🇬Singapore
- Country
- 🇸🇬Singapore
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.scgcell.com
A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
Phase 1
Recruiting
- Conditions
- HCCHepatitis B Virus Related Hepatocellular CarcinomaHepatocellular Carcinoma
- Interventions
- First Posted Date
- 2024-09-27
- Last Posted Date
- 2024-09-27
- Lead Sponsor
- SCG Cell Therapy Pte. Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT06617000
- Locations
- 🇨🇳
Beijing, Beijing, Beijing, China
🇨🇳Guangzhou, Guangzhou, Guangdong, China
🇨🇳Zhengzhou, Zhengzhou, Henan, China
Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma
Phase 1
Not yet recruiting
- Conditions
- HPV-Related Squamous Cell CarcinomaHPV-Related Cervical Squamous Cell CarcinomaHPV-Related Vulvar Squamous Cell CarcinomaHPV-Related Penile Squamous Cell CarcinomaHPV-Related Vaginal Squamous Cell CarcinomaHPV-Related Anal Squamous Cell CarcinomaHPV-Related Head and Neck Cancer
- Interventions
- First Posted Date
- 2024-07-17
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- SCG Cell Therapy Pte. Ltd.
- Target Recruit Count
- 66
- Registration Number
- NCT06505551
A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
Phase 1
Recruiting
- Conditions
- Hepatitis B Virus Related Hepatocellular CarcinomaHepatocellular Carcinoma Recurrent
- Interventions
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- SCG Cell Therapy Pte. Ltd.
- Target Recruit Count
- 46
- Registration Number
- NCT05417932
- Locations
- 🇺🇸
New York, New York, New York, United States
ðŸ‡ðŸ‡°Hong Kong is., Hong Kong, Hong Kong
ðŸ‡ðŸ‡°Hong Kong NT, Hong Kong, Hong Kong
© Copyright 2025. All Rights Reserved by MedPath